{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-022075","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2023-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.711427+00:00","generated_at":"2026-06-13T18:53:56.876131+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Daré Bioscience annual meeting results: directors elected, auditor ratified, say-on-pay approved","bullets":["Cheryl R. Blanchard elected with 22,509,430 votes for, 3,095,043 withheld; Sabrina Martucci Johnson with 23,447,732 for, 2,156,741 withheld.","Ratification of Mayer Hoffman McCann as auditor for FY2023: 48,270,018 for, 1,341,227 against, 262,151 abstentions.","Advisory say-on-pay approved: 22,399,824 for, 3,026,516 against, 178,133 abstentions; 24,268,923 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-022075","json":"https://secwatch.observer/filing/0001493152-23-022075.json","markdown":"https://secwatch.observer/filing/0001493152-23-022075.md","text":"https://secwatch.observer/filing/0001493152-23-022075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/0001493152-23-022075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T18:53:56.876131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6789809fec2c49ad2227f948a0ae5a8687ebe989","claim":"Dare Bioscience, Inc. shareholders approved Election of Class III directors at the 2023-06-21 meeting.","evidence_excerpt":"Each of the director nominees was elected as a Class III director to hold office until our 2026 annual meeting of stockholders, and until a successor is duly elected and qualified, by the votes set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/0001493152-23-022075-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-21"}],"fact_type":"shareholder_vote"},{"claim_id":"9a65adf6597f0ab1d272f09839eca06b60be021c","claim":"Dare Bioscience, Inc. shareholders approved Advisory approval of compensation of named executive officers at the 2023-06-21 meeting.","evidence_excerpt":"Our stockholders approved, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement by the votes set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/0001493152-23-022075-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-21"}],"fact_type":"shareholder_vote"},{"claim_id":"bfd67a8f48743e246067594afa4455be7f512a38","claim":"Dare Bioscience, Inc. shareholders approved Ratification of appointment of Mayer Hoffman McCann P.C. as independent registered public accounting firm at the 2023-06-21 meeting.","evidence_excerpt":"Our stockholders ratified the appointment of Mayer Hoffman McCann P.C.as our independent registered public accounting firm for the fiscal year ending December 31, 2023 by the votes set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/0001493152-23-022075-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-21"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}